Antigens, CD1d: Clinical Trials

1 trial of Antigens, CD1d, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Antigens, CD1d: new trials by email Literature Review of Antigens, CD1d trials Research Report on Antigens, CD1d

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors
Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML Injection - Non Small Cell Lung Cancer, Solid Tumor
Phase 2UnknownUniversitair Ziekenhuis Brussel362020-09-222022-09-14

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)

Sponsors

Universitair Ziekenhuis Brussel (1)

Countries

Belgium (1)

Results publications

PMID 38954010